Prospective, multicenter, randomized, self-controlled trial for IPL and ResurFx in the treatment of enlarged facial pores

Intense pulsed light with optimal pulse technology and 1565-nm nonablative fractional laser for enlarged facial pores: A Prospective, Randomized, Multicenter, Self-control Study.

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022179

Enrollment

Unknown

Registered

2019-03-28

Start date

2019-04-01

Completion date

Unknown

Last updated

2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

enlarged facial pores

Interventions

Group 1:IPL with optimal pulse technology

Group 2:1565-nm nonablative fractional laser

Eligibility

Sex/Gender

All

Age

14 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients that were diagnosed as enlarged facial pores by at least two plastic surgeons; (2) The age at the beginning of treatment was over 14 years old; (3) The parents signed informed consent, willing to accept the self-contro studyl with long-term trials, and with long-term follow-up.

Exclusion criteria

Exclusion criteria: 1. The presence of contraindications for laser; 2. Pregnant, breast-feeding women or women with pregnant plans; 3. The lesions were ulcer, infection and eczema; 4. The lesions caused serious or life-threatening dysfunction in children; 5. Other clinical trials of the patients received nearly six months; 6. other laser or injection treatment was received within 6 months.

Design outcomes

Primary

Measure	Time frame
number of facial pores;	—

Secondary

Measure	Time frame
Clinical efficiency;	—

Countries

China

Contacts

Public ContactMa Gang

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine

docmagang@126.com+86 13391063602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026